Position in ALKS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$184,867
+$53,717 QoQ
Shares Held
3,528
-4.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#311
of 424 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GF FUND MANAGEMENT CO. LTD. holds $3,495,212 across 29 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
56,606 | $898,903 | |
| 2 | ZTS |
Zoetis Inc.
|
12,182 | $875,398 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
840 | $455,137 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,987 | $334,888 | |
| 5 | ALKS |
Alkermes plc.
This page
|
3,528 | $184,867 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
6,656 | $115,215 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,648 | $108,647 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
973 | $62,223 |
All Filings in ALKS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $184,867 | 3,528 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $131,150 | 3,709 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $90,767 | 3,244 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $106,560 | 3,552 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $118,531 | 4,143 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $136,801 | 4,143 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $97,697 | 3,397 | Shares | Sole | 2025-02-19 | |
| No filing history on record for this holder in this stock. | ||||||